These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 28834373)
21. Childhood attention-deficit/hyperactivity disorder symptoms are risk factors for obesity and physical inactivity in adolescence. Khalife N; Kantomaa M; Glover V; Tammelin T; Laitinen J; Ebeling H; Hurtig T; Jarvelin MR; Rodriguez A J Am Acad Child Adolesc Psychiatry; 2014 Apr; 53(4):425-36. PubMed ID: 24655652 [TBL] [Abstract][Full Text] [Related]
22. Identifying developmental trajectories of body mass index in childhood using latent class growth (mixture) modelling: associations with dietary, sedentary and physical activity behaviors: a longitudinal study. Koning M; Hoekstra T; de Jong E; Visscher TL; Seidell JC; Renders CM BMC Public Health; 2016 Oct; 16(1):1128. PubMed ID: 27793201 [TBL] [Abstract][Full Text] [Related]
23. Stimulant treatment in children with attention-deficit/hyperactivity disorder moderates adolescent academic outcome. Powers RL; Marks DJ; Miller CJ; Newcorn JH; Halperin JM J Child Adolesc Psychopharmacol; 2008 Oct; 18(5):449-59. PubMed ID: 18928410 [TBL] [Abstract][Full Text] [Related]
24. Racial and Ethnic Disparities in ADHD Diagnosis and Treatment. Coker TR; Elliott MN; Toomey SL; Schwebel DC; Cuccaro P; Tortolero Emery S; Davies SL; Visser SN; Schuster MA Pediatrics; 2016 Sep; 138(3):. PubMed ID: 27553219 [TBL] [Abstract][Full Text] [Related]
25. Empathy and Facial Expression Recognition in Children With and Without Attention-Deficit/Hyperactivity Disorder: Effects of Stimulant Medication on Empathic Skills in Children with Attention-Deficit/Hyperactivity Disorder. Gumustas F; Yilmaz I; Yulaf Y; Gokce S; Sabuncuoglu O J Child Adolesc Psychopharmacol; 2017 Jun; 27(5):433-439. PubMed ID: 28332851 [TBL] [Abstract][Full Text] [Related]
26. Stimulant therapy in children with attention-deficit/hyperactivity disorder and concomitant long QT syndrome: A safe combination? Rohatgi RK; Bos JM; Ackerman MJ Heart Rhythm; 2015 Aug; 12(8):1807-12. PubMed ID: 25956966 [TBL] [Abstract][Full Text] [Related]
27. Academic and Social Functioning Associated with Attention-Deficit/Hyperactivity Disorder: Latent Class Analyses of Trajectories from Kindergarten to Fifth Grade. DuPaul GJ; Morgan PL; Farkas G; Hillemeier MM; Maczuga S J Abnorm Child Psychol; 2016 Oct; 44(7):1425-38. PubMed ID: 26750108 [TBL] [Abstract][Full Text] [Related]
28. Parent-Reported Improvements in Family Functioning in a Randomized Controlled Trial of Lisdexamfetamine for Treatment of Parental Attention-Deficit/Hyperactivity Disorder. Babinski DE; Waxmonsky JG; Waschbusch DA; Humphery H; Pelham WE J Child Adolesc Psychopharmacol; 2017 Apr; 27(3):250-257. PubMed ID: 27991835 [TBL] [Abstract][Full Text] [Related]
30. Protopathic stimulant use among children with symptoms of ADHD. Barnard-Brak L; To YM; Fearon DD Atten Defic Hyperact Disord; 2011 Sep; 3(3):245-51. PubMed ID: 21452045 [TBL] [Abstract][Full Text] [Related]
31. A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes. Faraone SV; Glatt SJ J Clin Psychiatry; 2010 Jun; 71(6):754-63. PubMed ID: 20051220 [TBL] [Abstract][Full Text] [Related]
32. Reduced salivary cortisol in children with comorbid Attention deficit hyperactivity disorder and oppositional defiant disorder. Kariyawasam SH; Zaw F; Handley SL Neuro Endocrinol Lett; 2002 Feb; 23(1):45-8. PubMed ID: 11880861 [TBL] [Abstract][Full Text] [Related]
33. Effect of prior stimulant treatment for attention-deficit/hyperactivity disorder on subsequent risk for cigarette smoking and alcohol and drug use disorders in adolescents. Wilens TE; Adamson J; Monuteaux MC; Faraone SV; Schillinger M; Westerberg D; Biederman J Arch Pediatr Adolesc Med; 2008 Oct; 162(10):916-21. PubMed ID: 18838643 [TBL] [Abstract][Full Text] [Related]